Multimodal Imaging Market Global Trends, Regional Growth, Industry Analysis by 2024 | Meticulous Research

Multimodal Imaging Market

A report into the projected growth of the current multimodal imaging systems market by Meticulous Research® has produced lucrative forecasts for the industry. By 2024, it’s expected to have grown at a CAGR of 5.3%, reaching $1.6 Billion.

Future Looks buoyant for multimodal imaging

In a report published today, Meticulous Research® has stated that the size of the global multimodal imaging systems market will reach an impressive $1.6 billion by 2024.

The researchers believe that explosive growth will be driven by a variety of factors. These include: increasing prevalence of chronic illness, technological advancements in imaging systems, and increasing adoption of preclinical imaging in drug discovery.

✅ Free Download and Gain Key Insights of this market here: https://www.meticulousresearch.com/request-sample-report/cp_id=4876

The multimodal imaging systems play an important role in addressing the issues for the treatment of chronically ill and aged population. The multimodal imaging is used in early detection of disease in areas such as oncology, neurology, cardiology, urology, and more. Multimodal imaging is widely used in the detection of tumor lesions for precise delivery of therapy.

The growth of global multimodal imaging market is driven by rapidly increasing geriatric population with prevalence of chronic illness, technological advancements in the development of imaging systems, and increasing drug discovery programs. However, high cost of instruments & imaging facility establishment and paucity of skilled healthcare professionals hinders the growth of this market. On the other hand, significant opportunities from developing economies are likely to offer high growth opportunities.

According to the United Nations, in 2017, population aged 60 years or over reached 962 million, which is expected to increase to 2.1 billion by 2050. Also, the number of people aged 80 years or above is projected to increase threefold between 2017 and 2050, rising from 137 million to 425 million. Also, according to Canadian Cancer Society, in Canada, it is estimated that by 2030, new cancer cases are expected to increase by about 40%. It is projected that by 2030, ~77,000 people will be diagnosed with cancer each year.

✅ Here are the top 10 companies in Multimodal Imaging Systems — https://meticulousblog.org/top-10-companies-in-multimodal-imaging-systems-market/

Scope of Multimodal Imaging Market Report:

Market by Product

• Multimodal imaging equipment
• Reagents
• Software

Market by Technology

• PET/CT
• SPECT/CT
• PET/MRI
• Others

Market by Application

• Clinical applications
• Oncology
• Cardiology
• Neurology
• Orthopedics
• Others
• Research applications

Market by End user

• Hospital
• Diagnostic centers
• Academic & research institutes
• Others

Market by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Spain
• Italy
• Rest of Europe (RoE)
• Asia-Pacific (APAC)
• Japan
• China
• India
• Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

✅ Browse full report with detailed TOC and list of figures and tables: https://www.meticulousresearch.com/product/multimodal-imaging-market/

Key findings in the global multimodal imaging systems market study:

Multimodal imaging equipment generated large proportion of revenue compared to reagents and software

Growing aging population coupled with chronic illnesses such as cancer, cardiovascular disorders, and neurological disorders are driving the adoption of multimodal imaging equipment. For instance, according to American College of Cardiology, in 2015, 42.7 million cases of cardiovascular diseases were reported globally. Similarly, according to WHO, every year, CVDs take the lives of 17.7 million people, which accounts for 31% of all the global deaths. Therefore, increasing incidence of chronic illness supports the demand for multimodal imaging equipment.

PET/CT to witness the largest demand through 2024

PET/CT commanded the largest share of the global multimodal imaging systems market in 2017 due to high sensitivity, specificity, and accuracy in characterization of tumors. Owing to these, the adoption of PET/CT technology is consistently increasing worldwide. In addition, most of the key players are engaged in the development of PET/CT systems, which led to the increase in the installation of PET/CT systems worldwide.

Clinical applications to dominate the multimodal imaging market in 2024

Clinical applications commanded the largest share of the global multimodal imaging market, mainly due to growing prevalence of chronic illness, which is leading to increasing volume of diagnostic examinations.

Hospitals to dominate the global multimodal imaging systems market

Hospitals commanded the largest share of the global multimodal imaging market with the growing healthcare expenditure across the globe, and increasing prevalence of various chronic diseases resulting in rising demand for early diagnosis and treatment in hospitals.

Asia-Pacific: Fastest growing regional market

North America commanded the largest share of the global multimodal imaging market; however, Asia-Pacific will be the fastest growing regional market due to accelerated economic growth of many countries in this region; growing government focus on healthcare sector; and rising pharmaceutical research activities. In addition, government initiatives towards the development of healthcare facilities and increasing health insurance penetration are the key factors propelling the growth of the Asia-Pacific multimodal imaging market.

Multimodal Imaging Market Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 5 years (2014–2018). The key players profiled in the global multimodal imaging systems market research report are GE Healthcare, Mediso Ltd., Siemens AG, Koninklijke Philips N.V., MR Solutions Ltd., Bruker Corporation, Canon Inc., Shanghai United Imaging Healthcare Co., Ltd., PerkinElmer, Inc., Northridge Tri-Modality Imaging, Inc., and MILabs B.V.

✅ To Purchase This Premium Report Click Here: https://www.meticulousresearch.com/buy_now.php?pformat=87&vformat=268

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1–646–781–8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research